Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 168,360
  • Shares Outstanding, K 19,374
  • Annual Sales, $ 25,620 K
  • Annual Income, $ -9,020 K
  • 60-Month Beta 1.16
  • Price/Sales 5.33
  • Price/Cash Flow N/A
  • Price/Book 21.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.12
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.45 +21.48%
on 01/02/20
10.25 -11.71%
on 01/22/20
+1.29 (+16.62%)
since 12/27/19
3-Month
6.30 +43.62%
on 11/14/19
10.25 -11.71%
on 01/22/20
+1.45 (+19.08%)
since 10/25/19
52-Week
4.05 +123.46%
on 03/25/19
10.25 -11.71%
on 01/22/20
+3.00 (+49.59%)
since 01/25/19

Most Recent Stories

More News
iCAD Showcases Technology for Cancer "Discovery to Recovery" including ProFound AI Platform and Xoft System at Arab Health 2020 in Dubai

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will showcase its latest advancements in cancer detection and...

ICAD : 9.05 (+4.14%)
iCAD Appoints Nathaniel Dalton to its Board of Directors

iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Nathaniel Dalton was appointed to its Board of Directors.

ICAD : 9.05 (+4.14%)
AMG : 79.80 (-3.75%)
iCAD's ProFound AI Joins Nuance AI Marketplace for Diagnostic Imaging

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Breast Health Solutions suite will be available on the...

ICAD : 9.05 (+4.14%)
iCAD to Showcase Leading Breast Health Solutions Suite Including Expanded ProFound AI(TM) Platform at RSNA Annual Meeting

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will showcase its Breast Health Solutions suite including the...

ICAD : 9.05 (+4.14%)
iCAD to Participate at the Piper Healthcare Conference

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will...

ICAD : 9.05 (+4.14%)
iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will...

ICAD : 9.05 (+4.14%)
iCAD Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2019

Continued strong momentum for ProFound AI(TM) iCAD's proprietary cancer detection AI technology

ICAD : 9.05 (+4.14%)
iCAD to Report Third Quarter 2019 Financial Results on Wednesday, October 30

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and...

ICAD : 9.05 (+4.14%)
ProFound AI(TM) Platform Featured at Journees Francophones de Radiologie Congress in Paris

iCAD to Showcase Entire ProFound AI Platform, including its Solutions for 2D Mammography and Digital Breast Tomosynthesis in Paris at Medical Conference

ICAD : 9.05 (+4.14%)
iCAD Showcases ProFound AI(TM) Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will exhibit the ProFound AI(TM) platform, including...

ICAD : 9.05 (+4.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ICAD with:

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

2nd Resistance Point 9.98
1st Resistance Point 9.52
Last Price 9.05
1st Support Level 8.51
2nd Support Level 7.96

See More

52-Week High 10.25
Last Price 9.05
Fibonacci 61.8% 7.88
Fibonacci 50% 7.15
Fibonacci 38.2% 6.42
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar